{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:18:04Z","timestamp":1790810284981,"version":"4.1.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamadermatol.2019.3353","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:32:06Z","timestamp":1573644726000},"page":"57","source":"Crossref","is-referenced-by-count":208,"title":["Age-Specific Incidence of Melanoma in the United States"],"prefix":"10.1001","volume":"156","author":[{"given":"Kelly G.","family":"Paulson","sequence":"first","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Division of Medical Oncology, University of Washington, Seattle"},{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Gupta","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital, Seattle, Washington"},{"name":"Division of Dermatology, University of Washington, Seattle"},{"name":"Department of Pediatrics, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"},{"name":"Department of Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Veatch","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Division of Medical Oncology, University of Washington, Seattle"},{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Byrd","sequence":"additional","affiliation":[{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"},{"name":"Department of Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailender","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Division of Medical Oncology, University of Washington, Seattle"},{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wojcik","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude G.","family":"Chapuis","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Division of Medical Oncology, University of Washington, Seattle"},{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington"},{"name":"Division of Medical Oncology, University of Washington, Seattle"},{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Madeleine","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington School of Public Health, Seattle"},{"name":"Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington"},{"name":"Division of Dermatology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi190058r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017.","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"doi190058r3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma.","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"doi190058r4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma.","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"doi190058r5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis.","volume":"35","author":"D\u2019Angelo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"doi190058r6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9948","key":"doi190058r7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"issue":"26","key":"doi190058r8","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"25","key":"doi190058r9","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMc1714339","article-title":"Nivolumab and ipilimumab in advanced melanoma.","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"doi190058r10","first-page":"9","article-title":"Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.","volume":"10","author":"Wolchok","year":"2010","journal-title":"Cancer Immun"},{"issue":"5","key":"doi190058r11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1470-2045(18)30142-6","article-title":"Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.","volume":"19","author":"Dummer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"doi190058r12","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1158\/1078-0432.CCR-13-2054","article-title":"Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.","volume":"20","author":"Menzies","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"17","key":"doi190058r13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJM199904293401707","article-title":"The pathogenesis of melanoma induced by ultraviolet radiation.","volume":"340","author":"Gilchrest","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"doi190058r14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaad.2014.06.046","article-title":"Indoor tanning in businesses and homes and risk of melanoma and nonmelanoma skin cancer in 2 US case-control studies.","volume":"71","author":"Ferrucci","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"doi190058r15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.annepidem.2008.04.006","article-title":"Sunburns and risk of cutaneous melanoma: does age matter? a comprehensive meta-analysis.","volume":"18","author":"Dennis","year":"2008","journal-title":"Ann Epidemiol"},{"issue":"3","key":"doi190058r16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2188\/jea.JE20100145","article-title":"Heterogeneity in host risk factors for incident melanoma and non-melanoma skin cancer in a cohort of US women.","volume":"21","author":"Qureshi","year":"2011","journal-title":"J Epidemiol"},{"issue":"3","key":"doi190058r17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1200\/JCO.2010.28.7078","article-title":"Reduced melanoma after regular sunscreen use: randomized trial follow-up.","volume":"29","author":"Green","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"doi190058r18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jamadermatol.2018.1774","article-title":"Sunscreen use and melanoma risk among young Australian adults.","volume":"154","author":"Watts","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi190058r19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1542\/peds.2005-3109","article-title":"Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004.","volume":"118","author":"Cokkinides","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"doi190058r23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates.","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"doi190058r25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"1","key":"doi190058r27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40425-018-0397-8","article-title":"The age of enlightenment in melanoma immunotherapy.","volume":"6","author":"Albertini","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"5","key":"doi190058r28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/jamadermatol.2018.0028","article-title":"Prevalence of sun protection use and sunburn and association of demographic and behaviorial characteristics with sunburn among US adults.","volume":"154","author":"Holman","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi190058r29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjd.2018.178.issue-4","article-title":"The garment protection factor: further advances in labelling sun-protective clothing.","volume":"178","author":"Gefeller","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi190058r30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ijc.28956","article-title":"Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia.","volume":"136","author":"Iannacone","year":"2015","journal-title":"Int J Cancer"},{"issue":"21","key":"doi190058r31","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1200\/JCO.2005.02.899","article-title":"Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results database.","volume":"23","author":"Strouse","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"doi190058r32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1542\/peds.2012-2520","article-title":"Incidence of childhood and adolescent melanoma in the United States: 1973-2009.","volume":"131","author":"Wong","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"doi190058r33","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jpeds.2015.02.050","article-title":"Melanoma incidence in children and adolescents: decreasing trends in the United States.","volume":"166","author":"Campbell","year":"2015","journal-title":"J Pediatr"},{"issue":"2","key":"doi190058r34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of familial melanoma: 20 years after CDKN2A.","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"doi190058r35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2012.12.953","article-title":"Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children.","volume":"68","author":"Cordoro","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi190058r36","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv381","article-title":"Stemming the rising incidence of melanoma: calling prevention to action.","volume":"108","author":"Gershenwald","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"doi190058r37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamadermatol.2015.2938","article-title":"Association between indoor tanning and melanoma in younger men and women.","volume":"152","author":"Lazovich","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi190058r38","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1158\/1055-9965.EPI-13-0821","article-title":"Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study.","volume":"23","author":"Wu","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"doi190058r39","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/jid.2014.425","article-title":"The genomic landscape of childhood and adolescent melanoma.","volume":"135","author":"Lu","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi190058r40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/EDE.0000000000000963","article-title":"High birth weight, early UV exposure, and melanoma risk in children, adolescents, and young adults.","volume":"30","author":"Wojcik","year":"2019","journal-title":"Epidemiology"},{"issue":"1","key":"doi190058r41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v69.1","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"doi190058r20","volume-title":"Melanoma Incidence and Mortality, United States\u20142012\u20132016","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"doi190058r24","author":"Neter","year":"1985"},{"key":"doi190058r2","unstructured":"National Cancer Institute. NooneAM, HowladerN, KrapchoM, . SEER cancer statistics review (CSR) 1975-2015. https:\/\/seer.cancer.gov\/csr\/1975_2015\/. Updated September 10, 2018. Accessed March 1, 2019."},{"key":"doi190058r21","unstructured":"Centers for Disease Control and Prevention. 2001\u20132015 database: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence\u2014US Cancer Statistics Public Use Research Database, November 2017 submission (2001\u20132015), United States Dept of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Created on 4\/27\/2018. https:\/\/www.cdc.gov\/cancer\/uscs\/public-use. Published April 27, 2018. Accessed March 1, 2019."},{"key":"doi190058r22","unstructured":"Surveillance Research Program, National Cancer Institute. SEER*Stat software. https:\/\/seer.cancer.gov\/seerstat. Accessed March 1, 2019."},{"key":"doi190058r26","unstructured":"Introduction to SEER*Stat. https:\/\/seer.cancer.gov\/seerstat\/WebHelp\/seerstat.htm. Accessed August 1, 2019."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2754716\/jamadermatology_paulson_2019_oi_190058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T21:44:56Z","timestamp":1612302296000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2754716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.3353","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}